Neuralace Medical Completes Enrollment of Painful Diabetic Neuropathy Label Expansion Study (AT-PDN) Paving the Way for FDA Clearance and a Breakthrough, Non-invasive Treatment for Diabetes related Neuropathic Pain
This milestone marks the potential for significant expansion of the clinical benefits of neuromodulation to the millions of patients suffering from PDN who may not be candidates for implantable solutions but can benefit from non-invasive neuromodulation
